Artiva Biotherapeutics (ARTV) Other Accumulated Expenses: 2023-2025
Historic Other Accumulated Expenses for Artiva Biotherapeutics (ARTV) over the last 1 years, with Sep 2025 value amounting to $895,000.
- Artiva Biotherapeutics' Other Accumulated Expenses fell 59.65% to $895,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $895,000, marking a year-over-year decrease of 59.65%. This contributed to the annual value of $1.5 million for FY2024, which is 48.55% down from last year.
- Latest data reveals that Artiva Biotherapeutics reported Other Accumulated Expenses of $895,000 as of Q3 2025, which was down 10.23% from $997,000 recorded in Q2 2025.
- In the past 5 years, Artiva Biotherapeutics' Other Accumulated Expenses registered a high of $2.9 million during Q4 2023, and its lowest value of $895,000 during Q3 2025.
- Over the past 3 years, Artiva Biotherapeutics' median Other Accumulated Expenses value was $1.2 million (recorded in 2024), while the average stood at $1.6 million.
- Data for Artiva Biotherapeutics' Other Accumulated Expenses shows a maximum YoY plummeted of 59.65% (in 2025) over the last 5 years.
- Artiva Biotherapeutics' Other Accumulated Expenses (Quarterly) stood at $2.9 million in 2023, then plummeted by 48.55% to $1.5 million in 2024, then slumped by 59.65% to $895,000 in 2025.
- Its Other Accumulated Expenses stands at $895,000 for Q3 2025, versus $997,000 for Q2 2025 and $1.0 million for Q1 2025.